BioGrafting Aus
•Download as PPTX, PDF•
0 likes•52 views
BioGrafting Australia is developing a 3D printed bio-active scaffold infused with stem cells and growth factors as an alternative to painful autografts for bone repair, which require multiple surgeries and carry risks of complications. Their solution aims to promote bone regrowth and eradicate the need for autografts and implants. With over 4 million bone graft operations annually worldwide representing a $40 million market, BioGrafting Australia is seeking $500,000 to fund their second round of clinical trials and refine their scaffold composition as the next steps towards patenting and commercializing their formula.
Report
Share
Report
Share
Recommended
Presentation laniewski amber
This document proposes developing a new spinal bone graft called BioBridge Select. It summarizes RTI's current orthobiologics product lines and mission to advance science, safety, and innovation. The proposal suggests BioBridge Select will be a sterilized bone graft material for spinal repair surgery, utilizing RTI's proven BioCleanse sterilization process and distributed nationally. It is described as precisely shaped, safe and effective based on scientific evidence, and convenient for surgeons.
Custom Implants
OEMs and suppliers see promise in the ability of manufacturing and software to expand the use of custom implants in orthopaedics. Multiple companies are focused on the custom market. This session provides the surgeon perspective on these devices. What are the benefits? When should and shouldn't they be used? Will the market take off?
Cryocrate presentation for zoom 3.26.19
Whiteboard2Boardroom presents innovations from regional universities, hospitals, research organizations to encourage commercialization.
Laboratory Microscopes
Laboratory Products - We are manufacturer and suppliers of Laboratory Products, Laboratory Product Supplies, Lab Products, Laboratory Glassware and Laboratory Plasticware
GenScript ProBio: The World's Leading Biotech Company
GenScript ProBio is the world's leading biotech company founded in 2002 in New Jersey USA. We started a business in gene synthesis and established integrated innovative biologics CDMO platforms As of now, provide various solutions based on gene synthesis technology including gene and cell therapy vectors, biologics development and lentivirus manufacturing. Our team and leaders have years of experience in global biopharma companies and are committed to providing professional regulatory support for CMC development of biological products. We have the confidence to provide strong support for your projects. Visit our website for more information
https://www.genscriptprobio.com/gct-one-stop-lentiviralvector.html
2018 Thermo Fisher Scientific Company Overview
As the world leader in serving science, we empower our people to advance innovative technologies, develop meaningful solutions, and build rewarding careers. With revenues of $20 billion and the largest investment in R&D in the industry, we give our 70,000 extraordinary minds the resources and opportunities to make significant contributions to the world.
Explore the professional possibilities at Thermo Fisher Scientific, and join us.
OneStart 2013 Finalists (Europe)
Pitches from the 10 finalist teams selected to compete for the £100,000 Grand Prize of the inaugural OneStart competition in 2013, hosted by the Oxbridge Biotech Roundtable and SR One.
Learn more about this year's competition: http://oxbridgebiotech.com/onestart
Nrc slides
This document summarizes a new porous titanium dental implant technology called Ti FoamTM that is created using nanotechnology. It has the following key advantages over other dental implants: 1) Its porous structure mimics bone to facilitate rapid bone growth; 2) Growth enhancers and antibiotics embedded in the material promote even faster healing within days rather than months; 3) The expanded surface area of the porous material allows it to bond twice as much bone. This positioning opens opportunities in a large and growing $3.5 billion global dental implant market. The technology has completed development and testing and seeks $1.5 million in initial funding to commercialize the product.
Recommended
Presentation laniewski amber
This document proposes developing a new spinal bone graft called BioBridge Select. It summarizes RTI's current orthobiologics product lines and mission to advance science, safety, and innovation. The proposal suggests BioBridge Select will be a sterilized bone graft material for spinal repair surgery, utilizing RTI's proven BioCleanse sterilization process and distributed nationally. It is described as precisely shaped, safe and effective based on scientific evidence, and convenient for surgeons.
Custom Implants
OEMs and suppliers see promise in the ability of manufacturing and software to expand the use of custom implants in orthopaedics. Multiple companies are focused on the custom market. This session provides the surgeon perspective on these devices. What are the benefits? When should and shouldn't they be used? Will the market take off?
Cryocrate presentation for zoom 3.26.19
Whiteboard2Boardroom presents innovations from regional universities, hospitals, research organizations to encourage commercialization.
Laboratory Microscopes
Laboratory Products - We are manufacturer and suppliers of Laboratory Products, Laboratory Product Supplies, Lab Products, Laboratory Glassware and Laboratory Plasticware
GenScript ProBio: The World's Leading Biotech Company
GenScript ProBio is the world's leading biotech company founded in 2002 in New Jersey USA. We started a business in gene synthesis and established integrated innovative biologics CDMO platforms As of now, provide various solutions based on gene synthesis technology including gene and cell therapy vectors, biologics development and lentivirus manufacturing. Our team and leaders have years of experience in global biopharma companies and are committed to providing professional regulatory support for CMC development of biological products. We have the confidence to provide strong support for your projects. Visit our website for more information
https://www.genscriptprobio.com/gct-one-stop-lentiviralvector.html
2018 Thermo Fisher Scientific Company Overview
As the world leader in serving science, we empower our people to advance innovative technologies, develop meaningful solutions, and build rewarding careers. With revenues of $20 billion and the largest investment in R&D in the industry, we give our 70,000 extraordinary minds the resources and opportunities to make significant contributions to the world.
Explore the professional possibilities at Thermo Fisher Scientific, and join us.
OneStart 2013 Finalists (Europe)
Pitches from the 10 finalist teams selected to compete for the £100,000 Grand Prize of the inaugural OneStart competition in 2013, hosted by the Oxbridge Biotech Roundtable and SR One.
Learn more about this year's competition: http://oxbridgebiotech.com/onestart
Nrc slides
This document summarizes a new porous titanium dental implant technology called Ti FoamTM that is created using nanotechnology. It has the following key advantages over other dental implants: 1) Its porous structure mimics bone to facilitate rapid bone growth; 2) Growth enhancers and antibiotics embedded in the material promote even faster healing within days rather than months; 3) The expanded surface area of the porous material allows it to bond twice as much bone. This positioning opens opportunities in a large and growing $3.5 billion global dental implant market. The technology has completed development and testing and seeks $1.5 million in initial funding to commercialize the product.
2019 Thermo Fisher Scientific Company Overview
Thermo Fisher Scientific is the world leader in serving science, with $24 billion in revenues and 70,000 employees globally. They empower their employees to advance innovative technologies and build rewarding careers. They give their employees resources and opportunities to make significant contributions. Thermo Fisher Scientific enables their customers to make the world healthier, cleaner and safer through their industry-leading capabilities and unmatched global reach.
Anteo Diagnostics Microcap Presentation October 2013
Anteo Diagnostics, Biotech, Microcap, Investing, ASX, Stockmarket, Geoff Cumming, Alere, Philips Healthcare, BBI Solutions
SILS 2015 - Innovation at GE Healthcare
By: Fiona Fitzgerald, GE Healthcare Canada
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
Challenges and Opportunities for the Pharmaceutical Industry
Gino Martini, EIPG President
Presentation at Symposium at the Faculty of Pharmacy, University of Alcala, Madrid 2011
Therapure Bio Contact Presentation Sept 29 08
Therapure Biopharma is a Canadian biopharmaceutical company focused on overcoming manufacturing barriers for protein therapeutics. It has a large-scale, cGMP compliant facility for protein purification, cell culture, formulation, fill, and lyophilization. Therapure offers clients access to its manufacturing capabilities and aims to advance its own pipeline of four protein-based drug candidates. It also provides financing partnerships through equity stakes, licensing agreements, and joint development opportunities to help clients develop biopharmaceutical products.
Stratified Medicine - Setting the Scene
The document discusses a conference on stratified medicine opportunities for business. It provides an agenda for the conference, including welcome addresses, presentations on the national vision for stratified medicine and the Leicester Diagnostic Development Unit. It also summarizes information about BioCity Nottingham, including its business model, companies located there, growth, and focus for 2013 on sustaining business success and increasing the birth rate of new companies.
Vestibulator deck
Transpact Enterprises Private Limited, a Social Enterprise launched in the year 2013 , incubated at SINE-IIT Bombay & accelerated under CIIE IIM Ahmedabad. It is starts up to design, development, manufacturing, and distribution of therapeutic devices and rehabilitations services.
The aim of Transpact is to produce significantly needed Medico-products which are the necessity for betterment of Human Society. Ultimately allowing people to TRANScend their barriers and thus, create a positive imPACT on their lives.
Our Vision is to impact lives of people through continuous technological interventions and innovations by providing innovative, cost-effective and comprehensive solutions, products and services with strategic partnerships and collaborative relationships to help specially abled people to transcend their barriers.
We are located at SINE, CSIR Building , IIT-Bombay Campus, Powai Mumbai and having head office at 204, Timmy Arcade, Makwana Road Marole Andheri Mumbai, India . We have successfully accomplished the ISO 13485:2016 certification for medical devices. Our pursuit for the excellent quality is reflected in the ISO 9001:2015 certification for quality management system.
Israel technology incubators 2008
This document provides an overview of Israel's Technological Incubators Program. The program supports over 200 startup projects across 24 incubators annually. It aims to develop innovative technological ideas into startups and help them raise private investments. Incubators provide funding, facilities, expertise and networking opportunities to projects in exchange for equity. Successful startups include Protalix, D-Pharm, Compugen, Sightline, Remon Medical, Mazor and others. The program has helped launch over 300 companies, with a 73% success rate in raising follow-on private funding. It has played a key role in making Israel a global leader in technology entrepreneurship.
Establishing an Irish Biotech Company, Kieran Curran, CEO of Gen Cell
Establishing an Irish Biotech Company, Kieran Curran, CEO of Gen Cell, at Bank of Ireland's Enterprise Breakfast Seminar at Thomand Park
Stem Sel_FARETE 2016
This document discusses new technologies for quality control and selection of stem cells for applications in regenerative medicine and cell therapy. It notes that the stem cell quality control and production market is growing rapidly and will be over $1.3 billion by 2018. A novel method is presented for tag-less isolation and sorting of living stem cells, with exclusive features like no cell manipulation, high purity, high cell recovery, and real-time monitoring. The company developing this technology is seeking marketing, sales, business scale-up, and investment partners to help bring their Celector product to market.
Most emerging biotech companies to watch.pdf
1) Evozyne uses evolution-based design and machine learning to engineer novel proteins to solve challenges in therapeutics and sustainability.
2) They have partnered with Takeda to develop an enzyme to treat a genetic disease, exceeding expectations, and are developing platforms for antibodies, gene editing, and gene optimization.
3) Evozyne aims to bring biology-based solutions to issues like carbon capture and untreated diseases by designing proteins with advanced functionality inspired by natural evolution.
Anteo Diagnostics ASX Spotlight Presentation March 2014
Anteo Diagnostics is an Australian biotechnology company that develops proprietary surface coatings called Mix&Go for use in diagnostics and life sciences. In 2013, Anteo achieved solid commercial progress including partnership agreements that are enhancing the prospects of becoming cash flow positive in 2014. Anteo is now focused on advancing near-term opportunities to generate licensing fees and royalties from Mix&Go and expanding into the large market for bioseparations.
Auxein medical Corporate profile
In over 60 countries, patients, doctors and partners alike depend on Auxein Medical to move forward. Every orthopaedic implant that we manufacture is built according to the highest quality standards. We take special pride in our dedicated team of experts that makes sure we stay in line with the stringent norms set by ISO 13485 2003, CE and US FDA 510k – a feat few in the industry have achieved.
In just seven years since inception the distinguishable quality and value advantage delivered by our generic orthopaedic implants has earned us the credibility to afford a rapidly expanding customer base, opportunities to provide OEM services to leading names in the industry as well as the confidence of the medical community at large.
Upon a strong foundation of proven customer satisfaction we are now building a world of exciting possibilities in R&D, innovation, customisation and education.
Productmgrwebinarfeb2013 130207112402-phpapp02
This document provides an overview of market research services from BioInformatics LLC for companies developing new life science products. It discusses the importance of conducting market research during new product development. Key stages in the product development process include generating ideas, assessing feasibility, development, and product launch. Market research methods that can be used during each stage are described, including focus groups, surveys, and conjoint analysis. Cost-effective options like virtual focus groups and RateMyProduct are also presented for companies with limited budgets.
Anteo Technologies - New York presentation 2015
- Anteo Diagnostics is an Australian biotechnology company that develops proprietary surface coatings called Mix&Go for use in healthcare, life sciences, and other industries.
- Mix&Go is a universal double-sided molecular coating that gently but strongly binds biomolecules to synthetic surfaces, addressing challenges in test miniaturization and cost reduction.
- Anteo's growth strategy includes licensing its intellectual property, expanding its coating technologies and applications, developing product pipelines that demonstrate Mix&Go's uses, exploring new market opportunities, and acquiring synergistic assets.
Md flux dx4 week 10
The document discusses an innovative nutritional diagnostic tool called MDflux that allows dietitians and doctors to precisely assess a patient's nutritional state and needs. It found that standard hospital care often results in overfeeding or undernourishment of patients. MDflux provides actionable data to personalize nutrition and support healing. Key learnings included that dietitians are the main stakeholders, there is potential in neonatal care, and a partnership could help scale internationally and obtain regulatory approvals. The total addressable market is estimated at $9 billion annually in the US.
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy Development
Agenda of the Webinar:
Cell and Gene Therapy Biomanufacturing Market: Trends and Key Developments
Awaited Technologies in the Cell and Gene Therapy Development
Regulatory Scenario – GMP/cGMP Guidelines
Biomanufacturing 4.0 - Adoption Scenario
Conclusion and Future Outlook
Food Systems: a 21st century One Health challenge
Unacceptable practises in industrial food production systems: Close confinement of pigs and poultry in cages; Barren environments with no enrichment; Routine mutilations; and Use of antibiotics for growth promotion and cover-up cruelty
Company profile
This document discusses the success of Wynlife, a biotechnology MLM company founded by Dr. Chris Fan. It summarizes Dr. Fan's background founding two other successful biotech companies. It outlines Wynlife's patented natural health products, global operations, marketing plan with high payouts up to 75%, and compensation plan to achieve different ranks. It promotes Wynlife as a new but growing opportunity with solid plans, easy duplicable systems, full company support and patented natural products.
WTF@OIS: WHAT’S THE FUTURE @OIS?
Presentation from OIS@ASCRS 2016
Co-Moderators:
Gilbert H. Kliman, MD, Managing Director – InterWest Partners
Stephen Slade, MD
Company Presentations
Equinox | John Berdahl, MD, Founder & CEO
Presbyopia Therapies | Jim McCollum, Co-Founder
Stroma Medical | Doug Daniels, CEO
Eyenovia | Curt LaBelle, MD, Director
Wicab | Robert Beckman, President & COO
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
More Related Content
Similar to BioGrafting Aus
2019 Thermo Fisher Scientific Company Overview
Thermo Fisher Scientific is the world leader in serving science, with $24 billion in revenues and 70,000 employees globally. They empower their employees to advance innovative technologies and build rewarding careers. They give their employees resources and opportunities to make significant contributions. Thermo Fisher Scientific enables their customers to make the world healthier, cleaner and safer through their industry-leading capabilities and unmatched global reach.
Anteo Diagnostics Microcap Presentation October 2013
Anteo Diagnostics, Biotech, Microcap, Investing, ASX, Stockmarket, Geoff Cumming, Alere, Philips Healthcare, BBI Solutions
SILS 2015 - Innovation at GE Healthcare
By: Fiona Fitzgerald, GE Healthcare Canada
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
Challenges and Opportunities for the Pharmaceutical Industry
Gino Martini, EIPG President
Presentation at Symposium at the Faculty of Pharmacy, University of Alcala, Madrid 2011
Therapure Bio Contact Presentation Sept 29 08
Therapure Biopharma is a Canadian biopharmaceutical company focused on overcoming manufacturing barriers for protein therapeutics. It has a large-scale, cGMP compliant facility for protein purification, cell culture, formulation, fill, and lyophilization. Therapure offers clients access to its manufacturing capabilities and aims to advance its own pipeline of four protein-based drug candidates. It also provides financing partnerships through equity stakes, licensing agreements, and joint development opportunities to help clients develop biopharmaceutical products.
Stratified Medicine - Setting the Scene
The document discusses a conference on stratified medicine opportunities for business. It provides an agenda for the conference, including welcome addresses, presentations on the national vision for stratified medicine and the Leicester Diagnostic Development Unit. It also summarizes information about BioCity Nottingham, including its business model, companies located there, growth, and focus for 2013 on sustaining business success and increasing the birth rate of new companies.
Vestibulator deck
Transpact Enterprises Private Limited, a Social Enterprise launched in the year 2013 , incubated at SINE-IIT Bombay & accelerated under CIIE IIM Ahmedabad. It is starts up to design, development, manufacturing, and distribution of therapeutic devices and rehabilitations services.
The aim of Transpact is to produce significantly needed Medico-products which are the necessity for betterment of Human Society. Ultimately allowing people to TRANScend their barriers and thus, create a positive imPACT on their lives.
Our Vision is to impact lives of people through continuous technological interventions and innovations by providing innovative, cost-effective and comprehensive solutions, products and services with strategic partnerships and collaborative relationships to help specially abled people to transcend their barriers.
We are located at SINE, CSIR Building , IIT-Bombay Campus, Powai Mumbai and having head office at 204, Timmy Arcade, Makwana Road Marole Andheri Mumbai, India . We have successfully accomplished the ISO 13485:2016 certification for medical devices. Our pursuit for the excellent quality is reflected in the ISO 9001:2015 certification for quality management system.
Israel technology incubators 2008
This document provides an overview of Israel's Technological Incubators Program. The program supports over 200 startup projects across 24 incubators annually. It aims to develop innovative technological ideas into startups and help them raise private investments. Incubators provide funding, facilities, expertise and networking opportunities to projects in exchange for equity. Successful startups include Protalix, D-Pharm, Compugen, Sightline, Remon Medical, Mazor and others. The program has helped launch over 300 companies, with a 73% success rate in raising follow-on private funding. It has played a key role in making Israel a global leader in technology entrepreneurship.
Establishing an Irish Biotech Company, Kieran Curran, CEO of Gen Cell
Establishing an Irish Biotech Company, Kieran Curran, CEO of Gen Cell, at Bank of Ireland's Enterprise Breakfast Seminar at Thomand Park
Stem Sel_FARETE 2016
This document discusses new technologies for quality control and selection of stem cells for applications in regenerative medicine and cell therapy. It notes that the stem cell quality control and production market is growing rapidly and will be over $1.3 billion by 2018. A novel method is presented for tag-less isolation and sorting of living stem cells, with exclusive features like no cell manipulation, high purity, high cell recovery, and real-time monitoring. The company developing this technology is seeking marketing, sales, business scale-up, and investment partners to help bring their Celector product to market.
Most emerging biotech companies to watch.pdf
1) Evozyne uses evolution-based design and machine learning to engineer novel proteins to solve challenges in therapeutics and sustainability.
2) They have partnered with Takeda to develop an enzyme to treat a genetic disease, exceeding expectations, and are developing platforms for antibodies, gene editing, and gene optimization.
3) Evozyne aims to bring biology-based solutions to issues like carbon capture and untreated diseases by designing proteins with advanced functionality inspired by natural evolution.
Anteo Diagnostics ASX Spotlight Presentation March 2014
Anteo Diagnostics is an Australian biotechnology company that develops proprietary surface coatings called Mix&Go for use in diagnostics and life sciences. In 2013, Anteo achieved solid commercial progress including partnership agreements that are enhancing the prospects of becoming cash flow positive in 2014. Anteo is now focused on advancing near-term opportunities to generate licensing fees and royalties from Mix&Go and expanding into the large market for bioseparations.
Auxein medical Corporate profile
In over 60 countries, patients, doctors and partners alike depend on Auxein Medical to move forward. Every orthopaedic implant that we manufacture is built according to the highest quality standards. We take special pride in our dedicated team of experts that makes sure we stay in line with the stringent norms set by ISO 13485 2003, CE and US FDA 510k – a feat few in the industry have achieved.
In just seven years since inception the distinguishable quality and value advantage delivered by our generic orthopaedic implants has earned us the credibility to afford a rapidly expanding customer base, opportunities to provide OEM services to leading names in the industry as well as the confidence of the medical community at large.
Upon a strong foundation of proven customer satisfaction we are now building a world of exciting possibilities in R&D, innovation, customisation and education.
Productmgrwebinarfeb2013 130207112402-phpapp02
This document provides an overview of market research services from BioInformatics LLC for companies developing new life science products. It discusses the importance of conducting market research during new product development. Key stages in the product development process include generating ideas, assessing feasibility, development, and product launch. Market research methods that can be used during each stage are described, including focus groups, surveys, and conjoint analysis. Cost-effective options like virtual focus groups and RateMyProduct are also presented for companies with limited budgets.
Anteo Technologies - New York presentation 2015
- Anteo Diagnostics is an Australian biotechnology company that develops proprietary surface coatings called Mix&Go for use in healthcare, life sciences, and other industries.
- Mix&Go is a universal double-sided molecular coating that gently but strongly binds biomolecules to synthetic surfaces, addressing challenges in test miniaturization and cost reduction.
- Anteo's growth strategy includes licensing its intellectual property, expanding its coating technologies and applications, developing product pipelines that demonstrate Mix&Go's uses, exploring new market opportunities, and acquiring synergistic assets.
Md flux dx4 week 10
The document discusses an innovative nutritional diagnostic tool called MDflux that allows dietitians and doctors to precisely assess a patient's nutritional state and needs. It found that standard hospital care often results in overfeeding or undernourishment of patients. MDflux provides actionable data to personalize nutrition and support healing. Key learnings included that dietitians are the main stakeholders, there is potential in neonatal care, and a partnership could help scale internationally and obtain regulatory approvals. The total addressable market is estimated at $9 billion annually in the US.
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy Development
Agenda of the Webinar:
Cell and Gene Therapy Biomanufacturing Market: Trends and Key Developments
Awaited Technologies in the Cell and Gene Therapy Development
Regulatory Scenario – GMP/cGMP Guidelines
Biomanufacturing 4.0 - Adoption Scenario
Conclusion and Future Outlook
Food Systems: a 21st century One Health challenge
Unacceptable practises in industrial food production systems: Close confinement of pigs and poultry in cages; Barren environments with no enrichment; Routine mutilations; and Use of antibiotics for growth promotion and cover-up cruelty
Company profile
This document discusses the success of Wynlife, a biotechnology MLM company founded by Dr. Chris Fan. It summarizes Dr. Fan's background founding two other successful biotech companies. It outlines Wynlife's patented natural health products, global operations, marketing plan with high payouts up to 75%, and compensation plan to achieve different ranks. It promotes Wynlife as a new but growing opportunity with solid plans, easy duplicable systems, full company support and patented natural products.
WTF@OIS: WHAT’S THE FUTURE @OIS?
Presentation from OIS@ASCRS 2016
Co-Moderators:
Gilbert H. Kliman, MD, Managing Director – InterWest Partners
Stephen Slade, MD
Company Presentations
Equinox | John Berdahl, MD, Founder & CEO
Presbyopia Therapies | Jim McCollum, Co-Founder
Stroma Medical | Doug Daniels, CEO
Eyenovia | Curt LaBelle, MD, Director
Wicab | Robert Beckman, President & COO
Similar to BioGrafting Aus (20)
Anteo Diagnostics Microcap Presentation October 2013
Anteo Diagnostics Microcap Presentation October 2013
Challenges and Opportunities for the Pharmaceutical Industry
Challenges and Opportunities for the Pharmaceutical Industry
Establishing an Irish Biotech Company, Kieran Curran, CEO of Gen Cell
Establishing an Irish Biotech Company, Kieran Curran, CEO of Gen Cell
Anteo Diagnostics ASX Spotlight Presentation March 2014
Anteo Diagnostics ASX Spotlight Presentation March 2014
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy Development
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy Development
Recently uploaded
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
Pharmacology of Drugs for Congestive Heart Failure
Congestive Heart failure is caused by low cardiac output and high sympathetic discharge. Diuretics reduce preload, ACE inhibitors lower afterload, beta blockers reduce sympathetic activity, and digitalis has inotropic effects. Newer medications target vasodilation and myosin activation to improve heart efficiency while lowering energy requirements. Combination therapy, following an assessment of cardiac function and volume status, is the most effective strategy to heart failure care.
RESPIRATORY DISEASES by bhavya kelavadiya
The Children are very vulnerable to get affected with respiratory disease.
In our country, the respiratory Disease conditions are consider as major cause for mortality and Morbidity in Child.
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)
Home
Organization
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
About AOMA: The Academy of Oriental Medicine at Austin offers a masters-level graduate program in acupuncture and Oriental medicine, preparing its students for careers as skilled, professional practitioners. AOMA is known for its internationally recognized faculty, award-winning student clinical internship program, and herbal medicine program. Since its founding in 1993, AOMA has grown rapidly in size and reputation, drawing students from around the nation and faculty from around the world. AOMA also conducts more than 20,000 patient visits annually in its student and professional clinics. AOMA collaborates with Western healthcare institutions including the Seton Family of Hospitals, and gives back to the community through partnerships with nonprofit organizations and by providing free and reduced price treatments to people who cannot afford them. The Academy of Oriental Medicine at Austin is located at 2700 West Anderson Lane. AOMA also serves patients and retail customers at its south Austin location, 4701 West Gate Blvd. For more information see www.aoma.edu or call 512-492-303434.
All about shoulder Joint ..
All about shoulder joint , Anatomy ,Examination, Special tests and radiology.
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Fallopian tube blockage may cause female infertility. For treatment, herbal medicine Fuyan Pill can be a solution.
Helminthiasis or Worm infestation in Children for Nursing students
Brief description worm infestation/Helminthiasis for Basic B.Sc Nursing students
Nutritional deficiency disorder in Child
Nutritional deficiency Disorder are problems in india.
It is very important to learn about Indian child's nutritional parameters as well the Disease related to alteration in their Nutrition.
Storyboard on Skin- Innovative Learning (M-pharm) 2nd sem. (Cosmetics)
Skin is the largest organ of the human body, serving crucial functions that include protection, sensation, regulation, and synthesis. Structurally, it consists of three main layers: the epidermis, dermis, and hypodermis (subcutaneous layer).
1. **Epidermis**: The outermost layer primarily composed of epithelial cells called keratinocytes. It provides a protective barrier against environmental factors, pathogens, and UV radiation.
2. **Dermis**: Located beneath the epidermis, the dermis contains connective tissue, blood vessels, hair follicles, and sweat glands. It plays a vital role in supporting and nourishing the epidermis, regulating body temperature, and housing sensory receptors for touch, pressure, temperature, and pain.
3. **Hypodermis**: Also known as the subcutaneous layer, it consists of fat and connective tissue that anchors the skin to underlying structures like muscles and bones. It provides insulation, cushioning, and energy storage.
Skin performs essential functions such as regulating body temperature through sweat production and blood flow control, synthesizing vitamin D when exposed to sunlight, and serving as a sensory interface with the external environment.
Maintaining skin health is crucial for overall well-being, involving proper hygiene, hydration, protection from sun exposure, and avoiding harmful substances. Skin conditions and diseases range from minor irritations to chronic disorders, emphasizing the importance of regular care and medical attention when needed.
ENVIRONMENTAL SANITATION in community setting
“Environmental sanitation means the art and science of applying sanitary, biological and physical science principles and knowledge to improve and control the environment therein for the protection of the health and welfare of the public”.The overall importance of sanitation are to provide a healthy living environment for everyone, to protect the natural resources (such as surface water, groundwater, soil ), and to provide safety, security and dignity for people when they defecate or urinate .Sanitation refers to public health conditions such as drinking clean water, sewage treatment, etc. All the effective tools and actions that help in keeping the environment clean come under sanitation. Sanitation refers to public health conditions such as drinking clean water, sewage treatment. All the effective tools and actions that help in keeping the environment clean and promotes public health is the necessary in todays life.
5 Effective Homeopathic Medicines for Irregular Periods
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
Gene Expression System-viral gene delivery Mpharm(Pharamaceutics)
Gene therapy can be broadly defined as the transfer of genetic material to cure a disease or at least to improve the clinical status of a patient.
One of the basic concepts of gene therapy is to transform viruses into genetic shuttles, which will deliver the gene of interest into the target cells.
Safe methods have been devised to do this, using several viral and non-viral vectors.
In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The biggest hurdle faced by medical research in gene therapy is the availability of effective gene-carrying vectors that meet all of the following criteria:
Protection of transgene or genetic cargo from degradative action of systemic and endonucleases,
Delivery of genetic material to the target site, i.e., either cell cytoplasm or nucleus,
Low potential of triggering unwanted immune responses or genotoxicity,
Economical and feasible availability for patients .
Viruses are naturally evolved vehicles that efficiently transfer their genes into host cells.
Choice of viral vector is dependent on gene transfer efficiency, capacity to carry foreign genes, toxicity, stability, immune responses towards viral antigens and potential viral recombination.
There are a wide variety of vectors used to deliver DNA or oligo nucleotides into mammalian cells, either in vitro or in vivo.
The most common vector system based on retroviruses, adenoviruses, herpes simplex viruses, adeno associated viruses.
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
In this presentation , SBP ( spontaneous bacterial peritonitis ) , which is a common complication in patients with cirrhosis and ascites is described in detail.
The reference for this presentation is Sleisenger and Fordtran's Gastrointestinal and Liver Disease Textbook ( 11th edition ).
Recently uploaded (20)
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
Pharmacology of Drugs for Congestive Heart Failure
Pharmacology of Drugs for Congestive Heart Failure
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Helminthiasis or Worm infestation in Children for Nursing students
Helminthiasis or Worm infestation in Children for Nursing students
Storyboard on Skin- Innovative Learning (M-pharm) 2nd sem. (Cosmetics)
Storyboard on Skin- Innovative Learning (M-pharm) 2nd sem. (Cosmetics)
5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods
pharmacy exam preparation for undergradute students.pptx
pharmacy exam preparation for undergradute students.pptx
Gene Expression System-viral gene delivery Mpharm(Pharamaceutics)
Gene Expression System-viral gene delivery Mpharm(Pharamaceutics)
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
BioGrafting Aus
- 2. The Problem Autografts for bone repair Painful Multiple Surgeries Risks of complications
- 3. Our Solution 3D printed bio-active scaffolds Infused with stem cells and growth factors Promote bone regrowth Eradicate autografts and implants
- 4. 4 million bone graft operations annually Market Size
- 5. Business Model Patent the formula for our bio-scaffold material Charge $10.00 for every graft produced 4 mil x $10.00 = potential $40 mil turnover annually!
- 6. Why BioGrafting Australia? World Leaders • We are leading the way in bone tissue engineering research Proven Success • Phase-1 in- human clinical trial was a success Skills & Attributes • Team of world- renowned scientists • Proven business admin and marketing experience
- 7. Traction to Date First in-human clinical trial completed in 2018 Second clinical trial planned for 2020
- 8. Next steps Step 1 • Refine our scaffold composition Step 2 • Phase-2 in- human trial in 2020 Step 3 • Patent our formula Step 4 • Take our formula to market
- 9. Why we need YOU! Groundbreaking technology Potential to improve millions of lives worldwide Race is on to be first to market We are seeking $500K to fund our second round of clinical trials
- 10. Contact Us Natalie Withington CEO, BioGrafting Australia Tel: 03 9214 50XX natalie@biograftingaus.com
Editor's Notes
- This is the question that your experiment answers
- Establish hypothesis before you begin the experiment. This should be your best educated guess based on your research.
- List all of the steps used in completing your experiment. Remember to number your steps.